CLINICAL_TRIALS
trial_result
· 2023-09-28
Clinical Trial Update: Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer [Phase 2]
Summary
Phase 2 randomized trial of genomically directed therapy in triple-negative breast cancer completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Bryan Schneider, MD | Conditions: Malignant Neoplasm of Breast, Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28